Short description
Athenex is a biopharmaceutical company that develops and discovers novel therapies for treating cancer and related conditions.
Description
Athenex focuses on the development and commercialization of therapies for cancer and immunomodulatory diseases. Its mission is to become a global leader in bringing innovative cancer treatments to the market and improve health outcomes.
The company was founded in 2003 in Buffalo, New York, and has since grown to have operations across the U.S., China, Hong Kong, Taiwan, and the U.K.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Buffalo, New York, United States, North America
Founded on
January 1, 2003
Exited on
June 14, 2017
Went public on
June 14, 2017
Stock symbol
ATNX
Non-profit?
No
Acquired?
No
Employees count
251-500
Revenue range
$34056 - 789030
Sign in for full access
Investors
No Way, Noway Youcantaccess, Noaccess, Noaccess
Sign in for full access
Founders
Allen Barnett, David Hangauer